Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vestibular Schwannoma
Scientists at Christian Medical College, Medical College target vestibular schwannoma
July 13th, 2009
In this recently published article, scientists in Vellore, India conducted a study "To determine the causes of delay in diagnosis and treatment of Indian patients with vestibular schwannomas. In a prospective study from 2003 to 2005, 50 patients with a confirmed diagnosis of vestibular schwannoma were interviewed to determine the causes for (1) the delay between the patient noting the initial symptom and the definitive diagnosis, and (2) the reasons for delayed diagnosis." "In 90 per cent of patients, the initial symptom was either hearing loss (62 per cent), vertigo (24 per cent) or tinnitus (4 per cent). However, most patients had been diagnosed and had presented for...
Source: Biotech Business Week (2009-07-13)
|
